较高的HLA-DRB1进化差异 (HED) 与降低衰退和改善匹配后的存活相关不相关的血液细胞移植细胞移植
Jennifer N Saultz1, Yung-Tsi Bolon2, Tao Wang3
1Division of Hematology/Oncology, Oregon Health & Sciences University Portland, Oregon, USA.
Transplantation and cellular therapy
|December 15, 2025
概括
较高的HLA-DRB1进化分歧 (HED) 分数与血液细胞移植 (HCT) 中更好的结果相关. 这表明HED可以预测血液恶性瘤的HCT后的复发减少和改善生存率.
科学领域:
- 免疫遗传学 免疫遗传学
- 造血细胞移植 造血细胞移植
- 癌症研究 癌症研究
背景情况:
- HLA进化分歧 (HED) 量化了免疫组的多样性.
- 患者-捐赠者对中的HED差异可能会影响全反应反应和移植结果.
- 移植对抗白血病 (GvL) 和移植对抗宿主 (GvHD) 影响在HCT中至关重要.
研究的目的:
- 为了确定更高的HED分数 (I和II类) 是否与改善的GvL效应和HCT后的存活率相关.
- 调查HED与主要造血细胞移植结果之间的关联.
主要方法:
- 分析了9231名从8/8个匹配的非相关捐赠者接受首次HCT的患者.
- 根据HLA-A,HLA-B,HLA-C和HLA-DRB的氨基酸序列计算HED1.
- 评估了HED四分位数与复发,无疾病生存率 (DFS),总生存率 (OS),TRM和GvHD之间的关联.
主要成果:
- 增加的HLA-DRB1 HED显著减少了复发,并改善了DFS和OS.
- 在HLA-DRB1 HED和TRM,急性/慢性GvHD或移植之间没有发现显著的关联.
- 更高的HLA类I HED没有显著影响OS,DFS,TRM,复发或GvHD.
结论:
- 较高的HLA-DRB1HED得分与降低复发和改善血液恶性瘤的HCT中的存活率有关.
- 研究结果支持HED对移植后结果的重要性.
- 需要进一步验证临床风险评估的整合.
关键词:
GvL GvL 的意思是什么头戴的头戴头戴的头戴头.在T细胞的全活性方面,T细胞的全活性移植 移植 移植 移植人类白细胞抗原.免疫皮组 (immunopeptidome) 是一个免疫皮组.这是一个复发的复发.更多相关视频
15:07VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma
Published on: December 28, 2015
27.2K
06:39Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
Published on: October 3, 2018
10.1K
相关概念视频
Bone Marrow Sampling and Transplants
816
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
816
Tissue Transplantation
864
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
864
Multipotency of Hematopoietic Stem Cells
3.8K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.8K
Regulation of Hematopoietic Stem Cells
3.9K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.9K
Cell-mediated Immune Responses
83.3K
Overview
83.3K
